Dysregulation of PDE4 and PDE5 activity has been implicated in the pathology of several neurodegenerative and neuropsychiatric disorders, including Alzheimer’s disease, stroke, and cognitive impairments [3,8,9,10,11,12]. Here, PDE5A is linked to early-onset autosomal dominant Alzheimer disease.